Remel Bile Esculin Azide Agar Recalled for Growth of E. faecalis
Remel Inc is recalling Bile Esculin Azide Agar with Vancomycin because the media allows growth of E. faecalis ATCC 29212.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity level where the use of the product may cause temporary or medically reversible health consequences, or where there is a remote probability of serious adverse health consequences. The specific defect is a performance issue (growth of E. faecalis) rather than a direct physical hazard like fire or shock.
Plain-English summary
Remel Inc is recalling Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186. The product is used in qualitative procedures as a screening method for primary isolation and presumptive identification of vancomycin-resistance enterococci (VRE) from surveillance cultures.
The recall was initiated because the media allows growth of E. faecalis ATCC 29212 with blackening of the media. This performance issue may affect the accuracy of the screening method.
The affected lot is #248035 with an expiration date of 2021-04-27. The product was distributed nationwide in the United States to the states of AZ, CA, CO, CT, GA, IA, IL, IN, MA, MI, MN, MO, NC, ND, OH, OR, PA, SD, TN, TX, and VA. There was government distribution and no military or foreign distribution. Users should stop using the affected product and contact Remel Inc for further instructions.
The recalled product
- Product
- Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package - Product Usage: use in qualitative procedures as a screening method for primary isolation and presumptive identification of vancomycin-resistance enterococci (VRE) from surveillance cultures.
- Manufacturer
- Remel Inc
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #248035
- Exp. 2021-04-27
Distribution
Related recalls
Same manufacturer · Remel Inc
See all →- HighGC Agar Base Culture Media Reduced Recovery of Neisseria gonorrhoeae
FDA (Devices) · 2026-07-08
- HighYeastone Broth recalled because it may report incorrect susceptibility results
FDA (Devices) · 2026-04-22
- SevereRemel Campy CVA Medium Lot Recalled Over Low Pathogen Recovery
FDA (Devices) · 2026-03-04
- ModerateCulture media recalled over contamination that may darken the broth
FDA (Devices) · 2025-12-03
- HighStrep Selective II Agar plates may carry Listeria monocytogenes contamination
FDA (Devices) · 2025-08-06
Same hazard · performance defect
See all →- ModerateBD GasPak EZ CO2 Pouch System gas generating sachets underperforming
FDA (Devices) · 2026-05-06
- ModerateBD GasPak EZ Campy Pouch System Recall for Below-Specification Gas Production
FDA (Devices) · 2026-05-06
- ModeratePhilips C5-2 Ultrasound Transducers Refurbished Beyond Useful Life
FDA (Devices) · 2025-07-09
- ModerateThermo SCIENTIFIC Sensititre Mueller-Hinton Broth diagnostic device recalled
FDA (Devices) · 2025-06-18
- ModerateID NOW COVID-19 2.0 Point-of-Care Test Device Recall
FDA (Devices) · 2025-04-23